TIMP1 and amyotrophic lateral sclerosis: Several of these factors may be relevant for potential therapeutic mechanism of action in ALS (e.g. Osteopontin, tissue inhibitor of metalloproteinase (TIMP)-1 and TIMP-2, Midkine, MIF; see Discussion).